Treatment Options for Stage III Unresectable NSCLC After Chemoradiotherapy
EP. 1: Immune Checkpoint Therapy Overview for Stage III NSCLC
February 15th 2019
EP. 2: The Unprecedented Data of Next-Generation Sequencing
February 15th 2019
EP. 3: The Impact of the PACIFIC Trial and Updated Analysis
February 15th 2019
EP. 4: Implications of Durvalumab Following PACIFIC Update
February 15th 2019
EP. 5: PACIFIC Trial Implications Concerning NSCLC Mutations
February 15th 2019
EP. 6: Durvalumab Following Chemoradiotherapy and Surgery
February 15th 2019
EP. 7: NSCLC Stage III Unmet Needs and Practical Advice
February 15th 2019
